Dihydroxyaluminum Aminoacetate

57 interactions
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Cabotegravir Cefuroxime Deferasirox Octreotide Injection Erdafitinib
15 Major 34 Moderate 8 Minor
All (57) Major (15) Moderate (34) Minor (8)

Major

Dihydroxyaluminum Aminoacetate Acalabrutinib Calquence Reduced acalabrutinib exposure Details Dihydroxyaluminum Aminoacetate Cabotegravir Apretude Reduced cabotegravir plasma concentrations Details Dihydroxyaluminum Aminoacetate Cefuroxime Ceftin® Decreased cefuroxime axetil exposure Details Dihydroxyaluminum Aminoacetate Deferasirox Exjade Decreased deferasirox effectiveness Details Dihydroxyaluminum Aminoacetate Digoxin Cardoxin® Reduced digoxin exposure Details Dihydroxyaluminum Aminoacetate Erdafitinib Balversa Altered serum phosphate levels Details Dihydroxyaluminum Aminoacetate Ezetimibe Zetia Reduced ezetimibe exposure Details Dihydroxyaluminum Aminoacetate Gefitinib Iressa Decreased exposure of gefitinib Details Dihydroxyaluminum Aminoacetate Hydroxychloroquine Plaquenil Reduced hydroxychloroquine exposure Details Dihydroxyaluminum Aminoacetate Infigratinib Truseltiq Decreased infigratinib plasma concentrations Details Dihydroxyaluminum Aminoacetate Ketoconazole Topical Extina® Foam Reduced ketoconazole exposure and reduced efficacy of ketoconazole Details Dihydroxyaluminum Aminoacetate Mefenamic Acid Ponstel® Increased exposure to mefenamic acid Details Dihydroxyaluminum Aminoacetate Neratinib Nerlynx Decreased neratinib exposure Details Dihydroxyaluminum Aminoacetate Octreotide Bynfezia Decreased octreotide bioavailability Details Dihydroxyaluminum Aminoacetate Octreotide Injection Bynfezia Decreased octreotide bioavailability Details

Moderate

Dihydroxyaluminum Aminoacetate Aspirin Acuprin® Decreased salicylate effectiveness Details Dihydroxyaluminum Aminoacetate Aspirin Rectal Aspirin Decreased salicylate effectiveness Details Dihydroxyaluminum Aminoacetate Bosutinib Bosulif Reduced bosutinib exposure Details Dihydroxyaluminum Aminoacetate Captopril Capoten® Decreased captopril effectiveness Details Dihydroxyaluminum Aminoacetate Cefdinir Omnicef® Decreased cefdinir efficacy Details Dihydroxyaluminum Aminoacetate Cefpodoxime Banan® Decreased cefpodoxime effectiveness Details Dihydroxyaluminum Aminoacetate Chloroquine Aralen® Decreased efficacy of chloroquine Details Dihydroxyaluminum Aminoacetate Dasatinib Phyrago Reduced dasatinib exposure Details Dihydroxyaluminum Aminoacetate Deflazacort Emflaza Decreased deflazacort effectiveness Details Dihydroxyaluminum Aminoacetate Demeclocycline Declomycin® Reduced efficacy of tetracyclines Details Dihydroxyaluminum Aminoacetate Doxycycline Injection Acticlate Reduced efficacy of tetracyclines Details Dihydroxyaluminum Aminoacetate Erlotinib Tarceva Reduced erlotinib exposure Details Dihydroxyaluminum Aminoacetate Ethambutol Myambutol Decreased ethambutol serum concentrations Details Dihydroxyaluminum Aminoacetate Fexofenadine Allegra Decreased fexofenadine efficacy Details Dihydroxyaluminum Aminoacetate Folic Acid Folacin Reduced folic acid exposure and reduced efficacy of folic acid Details Dihydroxyaluminum Aminoacetate Gatifloxacin Ophthalmic Zymar® Loss of gatifloxacin efficacy Details Dihydroxyaluminum Aminoacetate Gemifloxacin Factive Decreased oral gemifloxacin effectiveness Details Dihydroxyaluminum Aminoacetate Ibandronate Boniva Decreased ibandronate effectiveness Details Dihydroxyaluminum Aminoacetate Ibandronate Injection Boniva Decreased ibandronate effectiveness Details Dihydroxyaluminum Aminoacetate Levofloxacin Levaquin Decreased oral levofloxacin effectiveness Details Dihydroxyaluminum Aminoacetate Levofloxacin Injection Levaquin Decreased oral levofloxacin effectiveness Details Dihydroxyaluminum Aminoacetate Levothyroxine Ermeza Reduced efficacy of levothyroxine Details Dihydroxyaluminum Aminoacetate Mesalamine Apriso Alteration of mesalamine bioavailability Details Dihydroxyaluminum Aminoacetate Mesalamine Rectal Canasa Alteration of mesalamine bioavailability Details Dihydroxyaluminum Aminoacetate Minocycline Amzeeq Reduced efficacy of minocycline Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.